rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

John J. Orloff

Director

Company insider

Files Form 4 as: Director, Zenas BioPharma; EVP, Research & Development, Alexion Pharmaceuticals; Director and Officer, Novelion Therapeutics; EVP and President, R&D, Baxalta.

Every Form 4 they filed

In numbers

Trades disclosed
37
Buys
0
Sells
1
Bought
$0
Sold
$251K
Companies
4
Companies where not an officer
1
First trade
1 Jul 2015
Last trade
15 Jun 2026
Last filed
17 Jun 2026

Companies traded

Where they are an officer
Alexion PharmaceuticalsOfficer · last 21 Jul 20210 buys · 1 sell
Novelion TherapeuticsDirector, Officer · last 9 Aug 20180 buys · 0 sells
BaxaltaOfficer · last 3 Jun 20160 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
ZBIO Zenas BioPharmaDirector · Biotechnology · last 15 Jun 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Jun 2026filed 17 Jun 2026ZBIO Zenas BioPharmaoption or derivative · BiotechnologySEC FORM 4 Code A—18,500 at $0.00filing
15 Jun 2026filed 17 Jun 2026ZBIO Zenas BioPharmaoption or derivative · BiotechnologySEC FORM 4 Code A—18,500 at $0.00filing
10 Jun 2025filed 12 Jun 2025ZBIO Zenas BioPharmaoption or derivative · BiotechnologySEC FORM 4 Code A—18,500 at $0.00filing
12 Sep 2024filed 16 Sep 2024ZBIO Zenas BioPharmaoption or derivative · BiotechnologySEC FORM 4 Code A—18,500 at $0.00filing
21 Jul 2021filed 23 Jul 2021Alexion PharmaceuticalsSEC FORM 4 Code D—146,511 at $0.00filing
14 Jul 2021filed 16 Jul 2021Alexion PharmaceuticalsSEC FORM 4 Code A—30,643 at $0.00filing
14 Jul 2021filed 16 Jul 2021Alexion PharmaceuticalsSEC FORM 4 Code A—29,501 at $0.00filing
8 Jun 2021filed 9 Jun 2021Alexion PharmaceuticalsSEC FORM 4 Code F$346K1,957 at $177.00filing
28 Feb 2021filed 2 Mar 2021Alexion PharmaceuticalsSEC FORM 4 Code A—24,473 at $0.00filing
16 Dec 2020filed 18 Dec 2020Alexion PharmaceuticalsSEC FORM 4 Code A—40,677 at $0.00filing
16 Dec 2020filed 18 Dec 2020Alexion PharmaceuticalsSEC FORM 4 Code F$2.9M18,134 at $157.96filing
16 Dec 2020filed 18 Dec 2020Alexion PharmaceuticalsSEC FORM 4 Code F$515K3,261 at $157.96filing
15 Dec 2020filed 18 Dec 2020Alexion PharmaceuticalsSEC FORM 4 Code A$3,74140 at $93.53filing
8 Jun 2020filed 9 Jun 2020Alexion PharmaceuticalsSEC FORM 4 Code F$319K2,784 at $114.61filing
2 Mar 2020filed 3 Mar 2020Alexion PharmaceuticalsSEC FORM 4 Code F$126K1,396 at $90.54filing
28 Feb 2020filed 3 Mar 2020Alexion PharmaceuticalsSEC FORM 4 Code A—10,880 at $0.00filing
15 Dec 2019filed 3 Mar 2020Alexion PharmaceuticalsSEC FORM 4 Code A$3,56738 at $93.86filing
7 Jun 2019filed 11 Jun 2019Alexion PharmaceuticalsSEC FORM 4 Code F$330K2,786 at $118.61filing
28 Feb 2019filed 5 Mar 2019Alexion PharmaceuticalsSEC FORM 4 Code A—9,428 at $0.00filing
28 Feb 2019filed 4 Mar 2019Alexion PharmaceuticalsSEC FORM 4 Code F$90K675 at $132.92filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed1

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.